Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neurostudies is a private U.S. clinical research site and contract research organization focused on neurology and other CNS-related clinical trials. The company appears to operate primarily from Port Charlotte, Florida, and has been involved as an investigative site in industry-sponsored studies in Alzheimer's disease, multiple sclerosis, and autonomic disorders. Public sources indicate participation in trials involving agents such as lecanemab, IGC-AD1, remibrutinib, teriflunomide, ofatumumab, and ampreloxetine. The business does not appear to develop its own drug pipeline; instead, it provides clinical trial execution, patient enrollment, and investigator-site capabilities for sponsors. Available records also show a historical Georgia entity, NeuroStudies.net, LLC, that was listed by Crunchbase as closed, while the Florida operating company Neurostudies, Inc. appears to remain active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neurostudies.